• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Fever

Fever - 134 Studies Found

Completed : A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
: Marburg Hemorrhagic Fever
: 2012-03-27
:
  • Drug: AVI-7288

Completed : Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
: Marburg Hemorrhagic Fever
: 2011-04-22
:
  • Drug: AVI-6003 Single intraven

Completed : Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults
: Hemorrhagic Fever, Ebola
: 2015-09-29
: Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device
Completed : Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
: Hemorrhagic Fever, Ebola
: 2015-01-12
: Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients.
Completed : Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
:
  • Acquired Bleeding Disorder
  • Dengue Haemorrhagic Fever

: 2012-05-14
:
  • Drug: activated recombinant human factor VII

Completed : Experimental Ebola Vaccine Trial
:
  • Hemorrhagic Fever, Ebola
  • Healthy

: 2003-11-04
: Drug: VRC-EBODNA012-00-VP
Not yet recruiting : African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
: Ebola
: 2016-12-22
:
  • Biological: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine

Recruiting : Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
: Ebola Virus Survivor
: 2016-02-24
: Drug: Favipiravir Cohort 1: Day 1 (inclusion) 4800 mg (240
Completed : GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
: Persistent Ebola Virus
: 2016-06-28
:
  • Drug: GS-5734 Daily GS-5734 de

Active, not recruiting : Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)
: Prevention of Ebola Infection
: 2015-07-17
:
  • Biological: V920 Consistency Lot A

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.